3 news items
Arvinas Announces Promotions of Ian Taylor, Ph.D. to President of Research and Development and Angela Cacace, Ph.D. to Chief Scientific Officer
ARVN
17 Jun 24
in oncology and neuroscience. Dr. Taylor will continue to be an important connection to outside stakeholders, including thought leaders, strategic partners
As Early-Onset Breast Cancer Cases Soar in North America and EU, Biotech Ramps Up Response
ARVN
ATOS
ICCM
30 Apr 24
year for the company and its stakeholders.
"The data from the randomized BRACELET-1 trial showcased
As Early-Onset Breast Cancer Cases Soar in North America and EU, Biotech Ramps Up Response
ARVN
ATOS
ICCM
30 Apr 24
will be a landmark year for the company and its stakeholders.
"The data from the randomized BRACELET-1 trial
- Prev
- 1
- Next